The molecules chosen were acetaminophen as the model compound for small molecules, a linear dextran with a molecular weight of 120 kDa as the model compound for high molecular weight drugs, and insulin, which was chosen as the model protein and also for its potential use in the treatment of diabetic retinopathy [8,9]. This evidence concerns the gene INS and diabetic retinopathy.